Get the Latest News on PARP Inhibitors
There are now two PARP inhibitors that have been approved to treat certain types of metastatic breast cancer. Clinical trials of other PARP inhibitors are now...
Read MoreLife with MBC: 10+ Years and Counting
Researchers are trying to learn why some women and men live for 10 years or more after a diagnosis of metastatic breast cancer. The answers may hold clues for...
Read MoreAll about Basket and Umbrella Trials
Basket trials and umbrella trials were created to help researchers study how tumors respond to targeted therapies. Basket trials, also known as bucket trials,...
Read MoreConsider a Retreat
Whether it’s one day or week, a retreat can provide an opportunity to form important connections with others and gain skills that can help you live with...
Read MoreWhat is CAR-T Cell Immunotherapy?
CAR-T is a personalized immunotherapy made from a patient’s white blood cells. The blood cells are removed from the patient and then modified with chimeric...
Read MoreNew Research Presented at San Antonio
The San Antonio Breast Cancer Symposium is a key breast cancer conference that takes place each year. Researchers often use this meeting to report results from...
Read MorePatient and Advocate Perspectives on San Antonio
Hundreds of breast cancer advocates attended the San Antonio Breast Cancer Symposium. Below you can listen to their podcasts and read about how they’ve...
Read MoreSupport for MBC Caregivers
Caregivers play a unique role in the lives of women and men with metastatic breast cancer. In this issue of MTT, we provide tips and resources to help caregivers...
Read MoreManaging Lymphedema
Lymphedema–swelling of the arm, hand, breast, or torso–is a side effect that can develop after breast surgery or radiation that can affect the quality...
Read MoreSEARCH OUR SITE
for past articles or specific information.